These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 24096016)

  • 21. Tumor-type-dependent vascular permeability constitutes a potential impediment to the therapeutic efficacy of liposomal oxaliplatin.
    Abu Lila AS; Matsumoto H; Doi Y; Nakamura H; Ishida T; Kiwada H
    Eur J Pharm Biopharm; 2012 Aug; 81(3):524-31. PubMed ID: 22554766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced anti-glioblastoma efficacy by PTX-loaded PEGylated poly(ɛ-caprolactone) nanoparticles: In vitro and in vivo evaluation.
    Xin H; Chen L; Gu J; Ren X; Wei Z; Luo J; Chen Y; Jiang X; Sha X; Fang X
    Int J Pharm; 2010 Dec; 402(1-2):238-47. PubMed ID: 20934500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and characterization of low-toxic amphiphilic chitosan derivatives and their application as micelle carrier for antitumor drug.
    Huo M; Zhang Y; Zhou J; Zou A; Yu D; Wu Y; Li J; Li H
    Int J Pharm; 2010 Jul; 394(1-2):162-73. PubMed ID: 20457237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Core-crosslinked pH-sensitive degradable micelles: A promising approach to resolve the extracellular stability versus intracellular drug release dilemma.
    Wu Y; Chen W; Meng F; Wang Z; Cheng R; Deng C; Liu H; Zhong Z
    J Control Release; 2012 Dec; 164(3):338-45. PubMed ID: 22800578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nanoparticle-mediated drug delivery to tumor neovasculature to combat P-gp expressing multidrug resistant cancer.
    Bai F; Wang C; Lu Q; Zhao M; Ban FQ; Yu DH; Guan YY; Luan X; Liu YR; Chen HZ; Fang C
    Biomaterials; 2013 Aug; 34(26):6163-74. PubMed ID: 23706689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo efficacy of paclitaxel-loaded injectable in situ-forming gel against subcutaneous tumor growth.
    Lee JY; Kim KS; Kang YM; Kim ES; Hwang SJ; Lee HB; Min BH; Kim JH; Kim MS
    Int J Pharm; 2010 Jun; 392(1-2):51-6. PubMed ID: 20298770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paclitaxel-liposome-microbubble complexes as ultrasound-triggered therapeutic drug delivery carriers.
    Yan F; Li L; Deng Z; Jin Q; Chen J; Yang W; Yeh CK; Wu J; Shandas R; Liu X; Zheng H
    J Control Release; 2013 Mar; 166(3):246-55. PubMed ID: 23306023
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation.
    Zhao P; Wang H; Yu M; Liao Z; Wang X; Zhang F; Ji W; Wu B; Han J; Zhang H; Wang H; Chang J; Niu R
    Eur J Pharm Biopharm; 2012 Jun; 81(2):248-56. PubMed ID: 22446630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Iron oxide @ polypyrrole nanoparticles as a multifunctional drug carrier for remotely controlled cancer therapy with synergistic antitumor effect.
    Wang C; Xu H; Liang C; Liu Y; Li Z; Yang G; Cheng L; Li Y; Liu Z
    ACS Nano; 2013 Aug; 7(8):6782-95. PubMed ID: 23822176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paclitaxel-loaded poly(N-vinylpyrrolidone)-b-poly(epsilon-caprolactone) nanoparticles: preparation and antitumor activity in vivo.
    Zhu Z; Li Y; Li X; Li R; Jia Z; Liu B; Guo W; Wu W; Jiang X
    J Control Release; 2010 Mar; 142(3):438-46. PubMed ID: 19896997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Iron oxide nanoparticles for sustained delivery of anticancer agents.
    Jain TK; Morales MA; Sahoo SK; Leslie-Pelecky DL; Labhasetwar V
    Mol Pharm; 2005; 2(3):194-205. PubMed ID: 15934780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cooperative dual-activity targeted nanomedicine for specific and effective prostate cancer therapy.
    Yang HW; Hua MY; Liu HL; Tsai RY; Chuang CK; Chu PC; Wu PY; Chang YH; Chuang HC; Yu KJ; Pang ST
    ACS Nano; 2012 Feb; 6(2):1795-805. PubMed ID: 22248493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy.
    Min KH; Park K; Kim YS; Bae SM; Lee S; Jo HG; Park RW; Kim IS; Jeong SY; Kim K; Kwon IC
    J Control Release; 2008 May; 127(3):208-18. PubMed ID: 18336946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficient inhibition of colorectal peritoneal carcinomatosis by drug loaded micelles in thermosensitive hydrogel composites.
    Gong C; Wang C; Wang Y; Wu Q; Zhang D; Luo F; Qian Z
    Nanoscale; 2012 May; 4(10):3095-104. PubMed ID: 22535210
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation.
    Danhier F; Lecouturier N; Vroman B; Jérôme C; Marchand-Brynaert J; Feron O; Préat V
    J Control Release; 2009 Jan; 133(1):11-7. PubMed ID: 18950666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of poly(sebacic acid-co-ricinoleic acid) biodegradable delivery system for intratumoral delivery of paclitaxel.
    Shikanov A; Vaisman B; Shikanov S; Domb AJ
    J Biomed Mater Res A; 2010 Mar; 92(4):1283-91. PubMed ID: 19343769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nanoassemblies containing a fluorouracil/zidovudine glyceryl prodrug with phospholipase A2-triggered drug release for cancer treatment.
    Jin Y; Yang F; Du L
    Colloids Surf B Biointerfaces; 2013 Dec; 112():421-8. PubMed ID: 24036626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Facile Fabrication of Tumor Redox-Sensitive Nanoassemblies of Small-Molecule Oleate Prodrug as Potent Chemotherapeutic Nanomedicine.
    Luo C; Sun J; Sun B; Liu D; Miao L; Goodwin TJ; Huang L; He Z
    Small; 2016 Dec; 12(46):6353-6362. PubMed ID: 27689847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Redox-sensitive micelles self-assembled from amphiphilic hyaluronic acid-deoxycholic acid conjugates for targeted intracellular delivery of paclitaxel.
    Li J; Huo M; Wang J; Zhou J; Mohammad JM; Zhang Y; Zhu Q; Waddad AY; Zhang Q
    Biomaterials; 2012 Mar; 33(7):2310-20. PubMed ID: 22166223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective tissue distribution and long circulation endowed by paclitaxel loaded PEGylated poly(ε-caprolactone-co-L-lactide) micelles leading to improved anti-tumor effects and low systematic toxicity.
    Wang F; Shen Y; Xu X; Lv L; Li Y; Liu J; Li M; Guo A; Guo S; Jin F
    Int J Pharm; 2013 Nov; 456(1):101-12. PubMed ID: 23968782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.